Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.1750 |
| Open | 0.1750 |
| Bid | 0.1700 x 0 |
| Ask | 0.1800 x 0 |
| Day's Range | 0.1750 - 0.1800 |
| 52 Week Range | 0.1100 - 0.4000 |
| Volume | 145,010 |
| Avg. Volume | 223,311 |
| Market Cap | 28.465M |
| Beta (5Y Monthly) | 1.57 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0070 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.40 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- CNW Group
ATAC Announces 2021 Exploration Plans
VANCOUVER, BC, March 4, 2021 /CNW/ - ATAC Resources Ltd. (TSXV: ATC) ("ATAC") is pleased to announce its plans for the upcoming 2021 exploration season, and extension and re-pricing of certain warrants.
- CNW Group
ATAC Identifies Multiple Gold-in-Soil Anomalies and Stakes Additional Claims at its East Goldfield Project, Nevada
16, 2021 /CNW/ - ATAC Resources Ltd. (TSXV: ATC) ("ATAC") is pleased to provide an update on exploration activities at its road-accessible East Goldfield Property (the "Property"), located in the Goldfield Mining District of Nevada.
- Barrons.com
A Busy Day for Biotech IPOs
Three biotechs—Sana Biotechnology, Landos Biopharma, and Sensei Biotherapeutics—and chemicals specialist Atotech made their public-market debut Thursday. Here's how they fared.
© 2021 Verizon Media. All rights reserved.
